Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stoter

Showing results (101-110 of 249) with videos related to

Pageof 25
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancerC J Rodenburg, K Nooter, H Herweijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Carcinoma of unknown primary: identification of a treatable subset?A van der Gaast, J Verweij, S C Henzen-Logmans, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladderG Stoter, A T van Oosterom, J H Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary siteA van der Gaast, S C Henzen-Logmans, A S Planting, et al.
British Journal of Cancer|March 1, 1995
Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell lineK Nooter, A W Boersma, R G Oostrum, et al.
British Journal of Cancer|March 1, 1995
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU GroupS D Fosså, J P Droz, G Stoter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Prolonged continuous hepatic artery infusion with interleukin-2 in unresectable liver metastases of colorectal cancer: a phase IA-B studyS H Goey, A M Eggermont, R Oskam, et al.
British Journal of Cancer|February 1, 1993
Oral piritrexim, an effective treatment for metastatic urothelial cancerR de Wit, S B Kaye, J T Roberts, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancerR L Jansen, R Slingerland, S H Goey, et al.
Critical Reviews in Clinical Laboratory Sciences|April 9, 1998
In vivo model systems in P-glycoprotein-mediated multidrug resistanceW van de Vrie, R L Marquet, G Stoter, et al.
Pageof 25

Showing results (101-110 of 249) with videos related to

Sort By:
Pageof 25
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancerC J Rodenburg, K Nooter, H Herweijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Carcinoma of unknown primary: identification of a treatable subset?A van der Gaast, J Verweij, S C Henzen-Logmans, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladderG Stoter, A T van Oosterom, J H Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary siteA van der Gaast, S C Henzen-Logmans, A S Planting, et al.
British Journal of Cancer|March 1, 1995
Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell lineK Nooter, A W Boersma, R G Oostrum, et al.
British Journal of Cancer|March 1, 1995
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU GroupS D Fosså, J P Droz, G Stoter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Prolonged continuous hepatic artery infusion with interleukin-2 in unresectable liver metastases of colorectal cancer: a phase IA-B studyS H Goey, A M Eggermont, R Oskam, et al.
British Journal of Cancer|February 1, 1993
Oral piritrexim, an effective treatment for metastatic urothelial cancerR de Wit, S B Kaye, J T Roberts, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancerR L Jansen, R Slingerland, S H Goey, et al.
Critical Reviews in Clinical Laboratory Sciences|April 9, 1998
In vivo model systems in P-glycoprotein-mediated multidrug resistanceW van de Vrie, R L Marquet, G Stoter, et al.
Pageof 25